D. M. Dastrup et al. / Tetrahedron 60 (2004) 901–906
905
21.8, 21.5, 18.8, 13.9, 12.9; HRMS (C16H22N2O2S) calcd
307.1475 (MHþ), found 307.1487.
3.4.2. 5-Ethyl-3-methyl-1-[2-(p-tosyl)-ethyl]-1H-pyra-
1
zole (12b). Yellow oil (59% yield). H NMR (400 MHz,
CDCl3) d 7.67 (m, 2H), 7.30 (m, 2H), 5.69 (s, 1H), 4.31 (m,
2H), 3.64 (m, 2H), 2.56 (q, J¼7.5 Hz, 2H), 2.42 (s, 3H),
2.06 (s, 3H), 1.21 (t, J¼7.5 Hz, 3H); 13C NMR (75 MHz,
CDCl3) d 148.7, 145.9, 145.2, 136.4, 130.2, 128.2, 103.9,
55.6, 42.1, 22.0, 19.0, 13.8, 13.1; HRMS (C15H20N2O2S)
calcd 293.1318 (MHþ), found 293.1295.
3.2.4. 3,5-Dimethyl-1-[2-(p-tosyl)-ethyl]-1H-pyrazole
1
(9d). White solid (89% yield). Mp 65–67 8C; H NMR
(300 MHz, CDCl3) d 7.68 (d, J¼8.2 Hz, 2H), 7.30 (d, J¼
8.4 Hz, 2H), 5.68 (s, 1H), 4.33 (m, 2H), 3.65 (m, 2H), 2.42
(s, 3H), 2.23 (s, 3H), 2.05 (s, 3H); 13C NMR (75 MHz,
CDCl3) d 148.3, 144.9, 139.4, 136.2, 129.9, 127.8, 105.4,
55.6, 41.9, 21.7, 13.4, 10.9; HRMS (C14H18N2O2S) calcd
279.1167 (MHþ), found 279.1141.
3.4.3. 5-Butyl-3-phenyl-1-[2-(p-tosyl)-ethyl]-1H-pyrazole
and 3-butyl-5-phenyl-1-[2-(p-tosyl)-ethyl]-1H-pyrazole
(12, entry d). Yellow oil (84% yield), 2.2:1 inseparable
1
3.2.5. 4-Butyl-3,5-dimethyl-1-[2-(p-tosyl)-ethyl]-1H-pyr-
azole (9e). Pale yellow solid (92% yield); mp 81–84 8C;
1H NMR (300 MHz, CDCl3) d 7.67 (d, J¼8.3 Hz, 2H), 7.28
(d, J¼8.3 Hz, 2H), 4.33 (m, 2H), 3.65 (m, 2H), 2.42 (s, 3H),
2.22 (t, J¼7.1 Hz, 2H), 2.14 (s, 3H), 2.00 (s, 3H), 1.33–1.26
(m, 4H), 0.90 (t, J¼6.9 Hz, 3H); 13C NMR (75 MHz,
CDCl3) d 146.9, 144.8, 136.2, 136.1, 129.8, 127.8, 117.0,
55.6, 42.1, 33.1, 23.2, 22.5, 21.7, 14.1, 11.8, 9.5; HRMS
(C18H26N2O2S) calcd 335.1793 (MHþ), found 335.1770.
mixture of regioisomers. H NMR (300 MHz, CDCl3) d
7.57–7.18 (m, 37H), 6.11 (s, 1H), 5.93 (s, 2.3H), 4.33 (m,
6.6H), 3.63 (m, 2.4H), 3.57 (m, 4.7H), 3.00 (m, 1.4H), 2.43
(m, 15.9H), 2.18 (s, 3.6H), 1.3 (m, 17.9H), 0.87 (m, 11H);
13C NMR (75 MHz, CDCl3) d 153.7, 151.0, 145.0, 144.9,
144.7, 136.1, 135.9, 133.4, 130.3, 130.0, 129.9, 129.1,
128.9, 128.8, 128.6, 128.3, 128.0, 127.7, 127.6, 125.5,
105.4, 101.8, 55.6, 50.8, 43.0, 42.4, 31.8, 30.7, 28.0, 25.2,
22.7, 22.5, 21.8, 21.6, 14.1, 14.0; HRMS (C22H26N2O2S)
calcd 383.1788 (MHþ), found 383.1783.
3.2.6. 4-Chloro-3,5-dimethyl-1-[2-(p-tosyl)-ethyl]-1H-
1
pyrazole (9f). White solid (69% yield); mp 80–82 8C; H
3.5. General procedure for formation of TSE-protected
5-aminopyrazoles from b-ketonitriles or b-amino-
acrylonitriles
NMR (400 MHz, CDCl3) d 7.63–7.61 (d, J¼8.1 Hz, 2H),
7.29–7.27 (d, J¼8.1 Hz, 2H), 4.35–4.31 (m, 2H), 3.71–
3.67 (m, 2H), 2.43 (s, 3H), 2.12 (s, 3H), 1.98 (s, 3H); 13C
NMR (75 MHz, CDCl3) d 145.2, 144.9, 135.9, 129.7, 127.6,
107.9, 55.1, 43.0, 21.7, 11.2, 9.3; HRMS (C14H17N2O2SCl)
calcd 313.0757 (MHþ), found 313.0772.
A solution of TSE–NHNH2 (6, 154 mg, 0.719 mmol) and
the b-ketonitrile or b-aminoacrylonitrile (0.497 mmol) in
glacial acetic acid (4 mL) was stirred at 65 8C for 14 h. The
solution was concentrated in vacuo and the residue was
purified by flash silica gel chromatography to give the
corresponding TSE-protected 5-aminopyrazole.
3.3. General procedure for deprotection of
TSE-protected pyrazoles
To a solution of a TSE protected pyrazole 9 (0.107 mmol) in
THF (5 mL) at 230 8C was added t-BuOK (428 mL, 1 M
in THF). The solution was warmed slowly to rt, and stirred
for an additional 1 h. The mixture was diluted with H2O
and extracted with EtOAc. The combined organic fractions
were dried (MgSO4) and concentrated in vacuo. The residue
was purified by flash silica gel chromatography (ethyl
acetate/hexanes, 2/3) to give the deprotected pyrazole 10
(Table 1).
3.5.1. 5-tert-Butyl-2-[2-(p-tosyl)-ethyl]-2H-pyrazol-3-yl-
1
amine (15a). 58%. H NMR (400 MHz, CDCl3) d 7.61 (d,
J¼8.3 Hz, 2H), 7.25 (d, J¼7.9 Hz, 2H), 5.28 (s, 1H), 4.33 (t,
J¼6.2 Hz, 2H), 3.77 (s, 2H), 3.68 (t, J¼6.4 Hz, 2H), 2.40 (s,
3H), 1.12 (s, 9H); 13C NMR (100 MHz, CDCl3) d 161.5,
144.9, 144.6, 136.4, 129.8, 127.4, 88.4, 55.7, 40.6, 32.2,
30.4, 21.8; HRMS (C16H23N3O2S) calcd 322.1589 (MHþ),
found 322.1564.
3.5.2. 5-Phenyl-2-[2-(p-tosyl)-ethyl]-2H-pyrazol-3-yl-
amine (15b). 50%. 1H NMR, (400 MHz, d6-DMSO) d
7.75 (d, J¼8.3 Hz, 2H), 7.54 (dd, J¼8.1, 1.5 Hz, 2H), 7.36
(d, J¼7.9 Hz, 2H), 7.28 (d, J¼7.9 Hz, 2H), 7.20 (t, J¼
7.3 Hz, 1H), 5.64 (s, 1H), 5.25 (s, 2H), 4.18 (t, J¼7.0 Hz,
2H), 3.77 (m, 2H), 2.32 (s, 3H); 13C NMR (100 MHz,
d6-DMSO) d 148.5, 144.9, 136.5, 134.4, 130.3, 128.7,
128.1, 127.5, 125.2, 86.6, 54.2, 41.2, 21.5; HRMS
(C18H19N3O2S) calcd 342.1198 (MHþ), found 342.1257.
3.4. General procedure for the formation of
TSE-protected pyrazoles 12 from ynones 11
A solution of TSE–NHNH2 (6, 154 mg, 0.719 mmol) and
ynone 11 (0.497 mmol) in glacial acetic acid (4 mL) was
stirred at 65 8C for 14 h. The solution was concentrated in
vacuo and the residue was purified by flash silica gel
chromatography (ethyl acetate/hexanes, 3/7) to give the
corresponding TSE-protected pyrazole 12 (Table 2).
3.5.3. 5-Methyl-4-phenyl-2-[2-(p-tosyl)-ethyl]-2H-pyra-
1
zol-3-ylamine (15c). 70%. H NMR, (400 MHz, CDCl3) d
3.4.1. 5-Phenyl-3-methyl-1-[2-(p-tosyl)-ethyl]-1H-pyra-
zole (12a). White solid, mp 89–92 8C (92% yield). A
sample for X-ray analysis was crystallized from CH2Cl2/
hexanes. 1H NMR (300 MHz, CDCl3) d 7.57–7.18 (m, 9H),
5.92 (s, 1H), 4.33 (m, 2H), 3.58 (m, 2H), 2.35 (s, 3H), 2.10
(s, 3H); 13C NMR (75 MHz, CDCl3) d 148.8, 145.0, 144.9,
136.0, 130.2, 130.0, 129.1, 128.9, 128.8, 128.1, 106.5, 55.6,
43.1, 21.8, 13.6; HRMS (C19H20N2O2S) calcd 341.1318
(MHþ), found 341.1319.
7.63 (d, J¼8.3 Hz, 2H), 7.39 (t, J¼7.5 Hz, 2H), 7.26–7.17
(m, 5H), 4.37 (t, J¼6.4 Hz, 2H), 3.96 (s, 2H), 3.72 (t, J¼
6.2 Hz, 2H), 2.40 (s, 3H), 2.03 (s, 3H); 13C NMR (100 MHz,
CDCl3) d 146.0, 144.6, 142.5, 136.1, 133.3, 129.7, 128.8,
128.4, 127.4, 125.9, 105.3, 55.3, 40.9, 21.8, 13.0; HRMS
(C19H21N3O2S) calcd 356.1432 (MHþ), found 356.1444.
The following compounds were isolated as acetamides to